| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Scientific Officer | EVP, Global Research And CSO
1 company
Altshuler David is an EVP, Chief Scientific Officer at VERTEX PHARMACEUTICALS INC / MA. Recent SEC Form 4 filings include 0 buys and 40 sells.
Estimated insider holdings value: $10.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 15, 2022 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Global Research And CSO | Sell | 34 | $308.61 | $10,492.74 | - | -2.0% | +14.4% | |
| Nov 7, 2022 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Global Research And CSO | Sale+OE | 1,303 | $303.04 | $394,858.63 | -0.5% | +0.5% | +24.7% | |
| Aug 8, 2022 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Global Research And CSO | Sale+OE | 1,212 | $292.26 | $354,218.60 | -0.7% | +3.2% | +17.2% | |
| Jul 19, 2022 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Global Research And CSO | Sale+OE | 17,865 | $288.65 | $5,156,729.70 | -9.0% | +2.6% | +23.8% | |
| Feb 25, 2022 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Global Research And CSO | Sell | 7,572 | $230.98 | $1,748,989.52 | -4.7% | +17.1% | +24.8% | |
| Feb 18, 2022 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Global Research And CSO | Sell | 4,312 | $230.97 | $995,949.18 | -1.7% | +11.3% | +27.9% | |
| Feb 14, 2022 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Global Research And CSO | Sell | 2,444 | $232.02 | $567,056.88 | -4.1% | +9.9% | +29.8% | |
| Feb 11, 2022 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Global Research And CSO | Sell | 2,297 | $235.02 | $539,836.69 | -0.9% | +3.0% | +27.2% | |
| Feb 2, 2022 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Global Research And CSO | Sale+OE | 4,660 | $251.47 | $1,171,842.12 | -1.0% | +6.1% | +19.8% | |
| Nov 15, 2021 | VRTX Vertex Pharmaceuticals Inc / Ma | EVP, Global Research And CSO | Sell | 34 | $187.22 | $6,365.40 | - | +23.7% | +63.4% |